We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Tanger
SKT
$4.83B
| $2.04M | 0.09% |
126,035
-6,413
| -5% | -$116K |
|
252
Tapestry
TPR
$30.1B
| $2.04M | 0.09% |
64,301
-40,354
| -39% | -$1.26M |
|
253
MongoDB
MDB
$24.4B
| $2.04M | 0.09% |
13,392
+3,931
| +42% | +$571K |
|
254
Equinor
EQNR
$91.8B
| $2.02M | 0.09% |
102,225
+39,221
| +62% | +$828K |
|
255
Huntsman Corp
HUN
$2.09B
| $2.02M | 0.09% |
98,733
+3,351
| +4% | +$70.3K |
|
256
Fortive
FTV
$19.5B
| $2M | 0.09% |
+38,856
| New | +$2.02M |
|
257
Salesforce
CRM
$148B
| $1.99M | 0.09% |
13,139
-77,678
| -86% | -$12.2M |
|
258
Realty Income
O
$61.9B
| $1.98M | 0.09% |
+29,609
| New | +$2.02M |
|
|
BBBY
259
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.96M | 0.09% |
+168,815
| New | +$2.5M |
|
260
Arch Capital
ACGL
$37.1B
| $1.96M | 0.09% |
52,854
+7,470
| +16% | +$255K |
|
261
RingCentral
RNG
$4.69B
| $1.96M | 0.09% |
+17,051
| New | +$1.97M |
|
|
TCF
262
DELISTED
TCF Financial Corporation
TCF
| $1.9M | 0.08% |
+91,155
| New | +$1.9M |
|
263
InterDigital
IDCC
$6.68B
| $1.89M | 0.08% |
+29,393
| New | +$1.96M |
|
264
Bank OZK
OZK
$5.55B
| $1.88M | 0.08% |
62,436
-45,038
| -42% | -$1.4M |
|
|
TMX
265
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.87M | 0.08% |
35,833
-14,146
| -28% | -$728K |
|
266
Bruker
BRKR
$9.34B
| $1.86M | 0.08% |
37,296
+15,713
| +73% | +$662K |
|
267
Ameriprise Financial
AMP
$47.8B
| $1.86M | 0.08% |
12,800
-30,989
| -71% | -$4.48M |
|
268
WEX
WEX
$6.22B
| $1.86M | 0.08% |
+8,927
| New | +$1.8M |
|
269
VICI Properties
VICI
$30.1B
| $1.86M | 0.08% |
84,213
+32,227
| +62% | +$720K |
|
270
Synopsys
SNPS
$76.7B
| $1.82M | 0.08% |
+14,165
| New | +$1.7M |
|
|
MZTI
271
The Marzetti Company
MZTI
$3.09B
| $1.82M | 0.08% |
12,224
-561
| -4% | -$84.1K |
|
272
Textron
TXT
$15.4B
| $1.8M | 0.08% |
33,852
-147,843
| -81% | -$7.5M |
|
273
SLM Corp
SLM
$4.83B
| $1.79M | 0.08% |
184,436
-48,241
| -21% | -$478K |
|
274
ON Semiconductor
ON
$33B
| $1.77M | 0.08% |
87,437
-304,419
| -78% | -$6.29M |
|
275
Chemours
CC
$2.58B
| $1.76M | 0.08% |
+73,204
| New | +$2.16M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.